Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.278,62
0,07%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Virios Therapeutics Inc (VIRI) Virios Therapeutics Inc (VIRI) Notizie

Virios Therapeutics Inc

VIRI
3,875
0,00 (0,00%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202415:30EDGAR2Form 8-K/A - Current report: [Amend]
21/11/202415:15EDGAR2Form 8-K - Current report
08/11/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:15EDGAR2Form 8-K - Current report
30/10/202414:25EDGAR2Form 8-K - Current report
17/10/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/10/202422:19EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
07/10/202414:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/10/202414:02EDGAR2Form 8-K - Current report
07/10/202413:05GLOBEVirios Therapeutics, Inc. and Wex Pharmaceuticals, Inc...
09/8/202416:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202415:30EDGAR2Form 8-K - Current report
08/8/202415:15GLOBEVirios Therapeutics Announces Second Quarter 2024 Financial..
01/8/202415:41GLOBEVirios Therapeutics to Report Second Quarter 2024 Financial..
23/7/202415:15GLOBEVirios Therapeutics Announces Completion of Enrollment in..
20/6/202415:15EDGAR2Form 8-K - Current report
12/6/202415:15EDGAR2Form 8-K - Current report
22/5/202419:30GLOBEVirios Therapeutics Announces Closing of $1.7 Million Public..
20/5/202422:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
20/5/202415:28EDGAR2Form 8-K - Current report
20/5/202402:53GLOBEVirios Therapeutics Announces Pricing of $1.7 Million Public..
17/5/202422:10GLOBEVirios Therapeutics Announces Proposed Public Offering of..
17/5/202422:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
10/5/202416:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:01EDGAR2Form 8-K - Current report
09/5/202413:45GLOBEVirios Therapeutics Announces First Quarter 2024 Financial..
07/5/202423:25EDGAR2Form 8-K - Current report
02/5/202415:15GLOBEVirios Therapeutics to Report First Quarter 2024 Financial..
26/3/202414:15GLOBEVirios Therapeutics Announces Publication of International..
08/3/202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/3/202422:30EDGAR2Form 8-K - Current report
01/3/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:25EDGAR2Form 8-K - Current report
29/2/202415:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
28/2/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:15GLOBEVirios Therapeutics Issues Shareholder Letter..
27/2/202422:15EDGAR2Form 8-K - Current report
02/2/202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
22/1/202415:33EDGAR2Form PRE 14A - Other preliminary proxy statements
22/1/202415:00GLOBEVirios Therapeutics Announces Plans to Advance..
Apertura: Min: Max:
Chiusura: 3,875

La tua Cronologia

NASDAQ
VIRI
Virios Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network